Project title: Novel radioligands to improve radiotherapy of NETs

Kuo-Shyan Lin, PhD BC Cancer, Canada

Kuo-Shyan Lin, PhD
  • Status: Active
  • Year(s): 2018
  • Grant Type: Pilot
  • Research Type: Translational
  • Primary Site: Other
  • Area of Inquiry: Clinical trials

General Description

Scientists will explore a novel, very stable compound that binds to NET cells’ somatostatin receptors (SSTR2) more tightly than lutetium 177 (Lu-177) dotatate. This new radiopharmaceutical will be compared with Lu-177 dotatate in disease models. Researchers hope tighter binding of this radiotherapeutic agent to cancer cell receptors will lead to higher radiation accumulation and improved cancer response.

Additional Details

  • City: Vancouver
  • Grant Duration: 1 year
« Back to all funded research projects